Nucleocytoplasmic transport of the RNA-binding protein CELF2 regulates neural stem cell fates.
CELF2
RNA-binding proteins
cell fate decision
cortical development
neural stem cells
neurodevelopmental disorder
neurogenesis
nucleocytoplasmic translocation
rare disease
translational repression
Journal
Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691
Informations de publication
Date de publication:
08 06 2021
08 06 2021
Historique:
received:
16
11
2020
revised:
23
03
2021
accepted:
13
05
2021
entrez:
9
6
2021
pubmed:
10
6
2021
medline:
10
2
2022
Statut:
ppublish
Résumé
The development of the cerebral cortex requires balanced expansion and differentiation of neural stem/progenitor cells (NPCs), which rely on precise regulation of gene expression. Because NPCs often exhibit transcriptional priming of cell-fate-determination genes, the ultimate output of these genes for fate decisions must be carefully controlled in a timely fashion at the post-transcriptional level, but how that is achieved is poorly understood. Here, we report that de novo missense variants in an RNA-binding protein CELF2 cause human cortical malformations and perturb NPC fate decisions in mice by disrupting CELF2 nucleocytoplasmic transport. In self-renewing NPCs, CELF2 resides in the cytoplasm, where it represses mRNAs encoding cell fate regulators and neurodevelopmental disorder-related factors. The translocation of CELF2 into the nucleus releases mRNA for translation and thereby triggers NPC differentiation. Our results reveal that CELF2 translocation between subcellular compartments orchestrates mRNA at the translational level to instruct cell fates in cortical development.
Identifiants
pubmed: 34107259
pii: S2211-1247(21)00577-5
doi: 10.1016/j.celrep.2021.109226
pii:
doi:
Substances chimiques
CELF Proteins
0
CELF2 protein, human
0
Nerve Tissue Proteins
0
RNA-Binding Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
109226Subventions
Organisme : CIHR
ID : PJT-165821
Pays : Canada
Informations de copyright
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests M.M. is employed by Blueprint Genetics. L.M. has received personal fees from Mendelian Ltd outside the submitted work. The other authors declare no competing interests.